Centene Executive Expects 2027 Earnings Growth
A Centene executive expects 2027 earnings growth off an updated baseline and guidance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Humana files 8-K on Regulation FD disclosure, affirms guidance
Humana filed an 8-K with an Regulation FD disclosure and said its 2026 adjusted EPS guidance remains at least $9.00. The filing also discussed 2027 Medicare Advantage Star Ratings and a planned investor update in December.
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported second-quarter results that topped Wall Street estimates and raised its full-year adjusted earnings and operating cash flow guidance, supported by higher premium yields and continued growth in its Carelon business. Adjusted earnings came in at $7.45 per share, bea